<DOC>
	<DOCNO>NCT00891722</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue blood laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor understand low-grade glioma develop young patient predict respond treatment . PURPOSE : This clinical trial study tumor tissue , blood sample , family history predict tumor development response treatment young patient low-grade glioma .</brief_summary>
	<brief_title>Tumor Tissue , Blood Samples , Family History Predicting Tumor Development Response Treatment Young Patients With Low-Grade Glioma</brief_title>
	<detailed_description>OBJECTIVES : - To develop good understand low-grade glioma tumor develop child adolescent . - To study genetic profile may predict response treatment provide clue tumor develop initially use tumor blood sample patient . OUTLINE : This multicenter study . - Retrospective data collection ( participant recruit study SIOP-LGG1 ) : During follow-up appointment study SIOP-LGG1 , biological parents* ask complete questionnaire family 's cancer history . They may complete questionnaire either clinic home . Participants may complete return questionnaire time throughout study . - Prospective data collection ( participant recruit study SIOP-LGG-2004 ) : Both biological parents* ask complete family history questionnaire provide information family 's cancer history . Participants may complete return questionnaire time throughout study . NOTE : *In circumstance either biological parent unable complete questionnaire , may complete patient diagnose low grade glioma ( 16 year old ) adoptive parent guardian , feel knowledge complete questionnaire . Tumor tissue blood sample collect SIOP-LGG1 SIOP-LGG-2004 analyze genetic profile predictive response treatment different pattern tumor development , natural tumor behavior , tumor sensitivity cancer therapy . Collected family data anonymised link biological sample collect . Samples store future molecular genetic study .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biological parent child adolescent patient diagnose low grade glioma ( LGG ) LGG patient participate 1 follow clinical trial : On active follow study SIOPLGG1 Children 's Cancer Leukemia Group center On study SIOPLGG2004 Adoptive parent guardian allow feel knowledge complete study questionnaire , provide either biological parent unable complete questionnaire PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>recurrent childhood brain stem glioma</keyword>
	<keyword>untreated childhood brain stem glioma</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>untreated childhood cerebellar astrocytoma</keyword>
	<keyword>childhood low-grade cerebral astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>childhood oligodendroglioma</keyword>
	<keyword>recurrent childhood visual pathway hypothalamic glioma</keyword>
	<keyword>untreated childhood visual pathway hypothalamic glioma</keyword>
	<keyword>childhood mixed glioma</keyword>
</DOC>